This result is in accordance with a study showing that miR-122 expression is decreased in CSC/CD133+ cells from several hepatic cancer cell lines, and that miR-122 re-expression is associated with reduced self-renewal capacities 45. This evidence concerns the gene PROM1 and liver cancer.